Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bedford Laboratories
Bedford Laboratories to Begin Shipping Pentostatin for Injection
August 31st, 2007
Bedford Laboratories(TM), a division of Ben Venue Laboratories, Inc., announced FDA approval to begin shipping Pentostatin for Injection. This product is AP rated and is equivalent to Nipent(R) by Hospira Inc. Pentostatin is indicated for the treatment of hairy cell leukemia. "In our continuing effort to offer the most comprehensive and cost effective line of oncology and oncology adjunct products in the multisource industry, Bedford Laboratories is once again very pleased to offer this very important product," said David Gaugh, Vice President of Bedford Laboratories. Bedford Laboratories will supply latex-free Pentostatin for Injection as a sterile...
Source: Drug Week (2007-08-31)
|
